将药物基因组学整合至电子健康记录并实现临床决策支持
本文描述了现有药物基因组学信息学模型、关键实施步骤及新兴资源,以促进药物基因组学临床决策支持(CDS)的开发。将药物基因组学CDS有效整合至电子健康记录(EHR)可应对实施挑战,包括药物基因组学临床知识量增加、检测结果持久性及结果解读复杂性。被动和主动CDS均可在诊疗点提供信息,指导系统性使用药物基因组学以主动优化药物治疗。
要点
- EHR中的CDS是整合药物基因组学至常规诊疗的关键工具。
- 实施需考虑临床工作流程、警报触发识别及结果解读工具。
- 基因-药物对的相关临床推荐须无缝整合至EHR工作流程中。
核心结论
- 带有CDS的EHR对于整理药物基因组学数据并在诊疗点传播患者特异性信息至关重要。
主要发现
- 药物基因组学是精准医学的重要组成部分。
- 被动和主动CDS均可在诊疗点提供信息,指导系统性使用药物基因组学以主动优化药物治疗。
- 已识别成功实施的关键考虑因素,包括临床工作流程、警报触发识别及结果解读工具。
临床怎么用
- 所有与基因-药物对相关的临床推荐必须总结并以无缝整合至EHR临床工作流程的方式呈现给临床医生。
- 在某些情况下,可整合EHR之外的辅助系统和应用以增强EHR能力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Existing pharmacogenomic informatics models, key implementation steps, and emerging resources to facilitate the development of pharmacogenomic clinical decision support (CDS) are described. SUMMARY: Pharmacogenomics is an important component of precision medicine. Informatics, especially CDS in the electronic health record (EHR), is a critical tool for the integration of pharmacogenomics into routine patient care. Effective integration of pharmacogenomic CDS into the EHR can address implementation challenges, including the increasing volume of pharmacogenomic clinical knowledge, the enduring nature of pharmacogenomic test results, and the complexity of interpreting results. Both passive and active CDS provide point-of-care information to clinicians that can guide the systematic use of pharmacogenomics to proactively optimize pharmacotherapy. Key considerations for a successful implementation have been identified; these include clinical workflows, identification of alert triggers, and tools to guide interpretation of results. These considerations, along with emerging resources from the Clinical Pharmacogenetics Implementation Consortium and the National Academy of Medicine, are described. CONCLUSION: The EHR with CDS is essential to curate pharmacogenomic data and disseminate patient-specific information at the point of care. As part of the successful implementation of pharmacogenomics into clinical settings, all relevant clinical recommendations pertaining to gene-drug pairs must be summarized and presented to clinicians in a manner that is seamlessly integrated into the clinical workflow of the EHR. In some situations, ancillary systems and applications outside the EHR may be integrated to augment the capabilities of the EHR.
引用
- Hicks JK, Dunnenberger HM, Gumpper KF, et al. Integrating pharmacogenomics into electronic health records with clinical decision support. Am J Health Syst Pharm. 2016. PMID: 27864204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。